K. Lallas , E. Chatziioannou , D. Durak , G. Frey , L.M. Serna Higuita , M-L. Rasch , A. Kyrgidis , Z. Apalla , U. Leiter-Stoppke , L. Flatz , A. Lallas , T.M.S. Amaral
{"title":"非疾病进展原因停用免疫检查点抑制剂以及对晚期黑色素瘤患者复发和生存的影响:一项系统综述和荟萃分析","authors":"K. Lallas , E. Chatziioannou , D. Durak , G. Frey , L.M. Serna Higuita , M-L. Rasch , A. Kyrgidis , Z. Apalla , U. Leiter-Stoppke , L. Flatz , A. Lallas , T.M.S. Amaral","doi":"10.1016/j.iotech.2024.100814","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100814"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"71P Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients: A systematic review and meta-analysis\",\"authors\":\"K. Lallas , E. Chatziioannou , D. Durak , G. Frey , L.M. Serna Higuita , M-L. Rasch , A. Kyrgidis , Z. Apalla , U. Leiter-Stoppke , L. Flatz , A. Lallas , T.M.S. Amaral\",\"doi\":\"10.1016/j.iotech.2024.100814\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73352,\"journal\":{\"name\":\"Immuno-oncology technology\",\"volume\":\"24 \",\"pages\":\"Article 100814\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-oncology technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590018824001114\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-oncology technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590018824001114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
71P Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients: A systematic review and meta-analysis